Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via "differentiation-based nano-therapy". (2015)
Attributed to:
Maximising the Impact of Graphene Research on Innovation through Materials Science, Chemistry and Engineering
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.3348
PubMed Identifier: 25708684
Publication URI: http://europepmc.org/abstract/MED/25708684
Type: Journal Article/Review
Volume: 6
Parent Publication: Oncotarget
Issue: 6
ISSN: 1949-2553